ABUS vs CLBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

ABUS

51.2
AI Score
VS
ABUS Wins

CLBT

49.6
AI Score

Investment Advisor Scores

ABUS

51score
Recommendation
HOLD

CLBT

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABUS CLBT Winner
Revenue 14.08M 475.68M CLBT
Net Income -33.50M 78.33M CLBT
Net Margin -237.9% 16.5% CLBT
Operating Income -38.16M 66.48M CLBT
ROE -43.7% 16.2% CLBT
ROA -35.4% 8.3% CLBT
Total Assets 94.62M 938.85M CLBT
Cash 18.01M 124.46M CLBT
Current Ratio 15.73 1.56 ABUS

Relative Price Performance (Last 90 Days)

ABUS 1M: -8.2% · 3M: +3.3% CLBT 1M: -4.5% · 3M: +13.5%

Current Technical Phase

ABUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.5 · Price: $4.34

CLBT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.9 · Price: $14.75

Fundamentals Snapshot

Metric ABUS CLBT
Market Cap
Forward P/E -35.0 22.3
Trailing P/E 5.1 54.0
Revenue (TTM)
Revenue Growth 100.5% 0.2%
Gross Margin 0.9% 0.8%
Operating Margin 0.9% 0.1%
EPS 0.86 0.27
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ABUS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.